EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission

Detalles Bibliográficos
Autores principales: Chacon-Araya, M., Ortendahl, J.D., Lee, J., Broder, M., Brusky, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256479/
http://dx.doi.org/10.1016/j.jval.2023.03.541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256479/
http://dx.doi.org/10.1016/j.jval.2023.03.541

Ejemplares similares